Creutzfeldt-Jakob disease, Heidenhain variant: Case report with MRI (DWI) findings;Doença de Creutzfeldt-Jakob forma heidenhain: Relato de caso com achados de ressonância magnética e DWI

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 A, 2004, Pages 347-352

  Arruda, Walter Oleschko ^a   Bordignon, Kelly C ^a   Milano, Jerônimo B ^a   Ramina, Ricardo ^a  

^a INSTITUTO DE NEUROLOGIA DE CURITIBA   (Brazil)

Author keywords

Creutzfeldt Jakob d sease; Dementia; Prion

Indexed keywords

CERULOPLASMIN; CHLORPROMAZINE; COPPER; LACTIC ACID; MEPACRINE; NEURON SPECIFIC ENOLASE; PHENYTOIN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAZIL; CASE REPORT; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CHOREOATHETOSIS; CREUTZFELDT JAKOB DISEASE; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; LABORATORY TEST; LIVER FUNCTION; LUNG COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; TEMPORAL LOBE; VENEREAL DISEASE REACTION TEST;

EID: 2642515720     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000200029     Document Type: Article

References (42)

1. Gadjdusek DC. Infectious amyloids: subacute spongencephalopathies as transmissible cerebral amyloidoses. In Fields BN, Knipe DM, Howley PM, (eds). Fields virology, 2nd ed., Philadelphia: Lippincott-Raven; 1996;131-144.
2. Milton A. How is Creutzfeldt-Jakob disease acquired? Neuroepidemiology 2000;19:55-61.
3. Creutzfeldt HG. Über eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiatry 1920;57:1-18.
4. Jakob A. Über eigenartige Erkrankungendes Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spastische Pseudosclerosencephalomyelopathies mit disseminierten Degenerationsherden). [Preliminary communication]. Dtsch Z Nervenheilkd 1921;70:132-146.
5. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy-Creutzfeldt-Jakob disease - the nature and progression of spongiform change. Brain 1978;101:333-344.
6. Holman RC, Khan AS, Kent J, et al. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology 1995;14:174-181.
7. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Arch Neurol 1979;5:177-188.
8. Tyler KL, Martin JB. Infections diseases of the central nervous system. Philadelphia: F.A. Davis 1993.
9. Prusiner SB. Genetic and infectious prion diseases. Arch Neurol 1993; 50:177-188.
10. nd ed, Philadelphia, 1998.
11. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-341.
12. Roos R, Gajdusek DC, Gibbs CJ Jr. The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 1973;96:1-20.
13. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
14. Prusiner SB, Hsiao KK, Bredesen DE, DeArmond SJ. Prion disease. In McKendall RR (ed). Handbook of clinical neurology, vol 56, Amsterdam: Elsevier 1989;543-580.
15. Zochodne DW, Young GB, McLachlan RS, et al. Creutzfeldt-Jakob disease without periodic sharp wave complexes. Neurology 1988;38:1056-1060.
16. Gloor P, Kalabay O, Giard N. The electroencephalogram in diffuse encephalopathies: electroencephalographic correlates of grey and white matter lesions. Brain 1968;91:779-801.
17. Beaudry P, Cohen P, Brandel JP, et al. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 1999;10:40-46.
18. Yun M, Wu W, Hood L, Harrington M. Human cerebrospinal fluid protein database-edition 1992. Electrophoresis 1992;13:1002-1013.
19. Blisard K, Davis L, Harrington M, et al. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci 1990;99:75-81.
20. Mao-Draayer Y, Braff SP, Nagle KJ, et al. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of die literature. Am J Neuroradiol 2002;23:550-556
21. Finkenstaedt A, Szudra I, Zerr S, et al. MR imaging of Creutzfeldt Jakob disease. Radiology 1996;199:793-798.
22. Gertz HJ, Henkes H, Cervos-Navarro J. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. Neurology 1998; 38:1481-1482.
23. Barboriak DP, Provenzalej M, Boyko OR. MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia. AJR 1994;162:137-140.
24. Garcia Santos JM, López Corbalán JA, Martinez-Lage JF, Sicília Guillén J. CT and MRI in iatrogenic and sporadic Creutzfeldt-Jakob disease: as far as imaging perceives. Neuroradiology 1996;38:226-231.
25. Milton WJ, Atlas SW, Lavi E, Mollmann JE. Magnetic resonance imaging of Creutzfeldt-Jakob disease. Ann Neurol 1991;29:438-440.
26. Onofrj M, Fulgente T, Gambi D, Macchi G. Early MRI findings in Creutzfeldt-Jakob disease. J Neurol 1993;240:423-424.
27. Pearl GS, Anderson RE. Creutzfeldt-Jakob disease: high caudate signal on magnetic resonance imaging. South Med J 1989;82:1177-1180.
28. Di Rocco A, Yahr MD. MRI abnormalities in Creutzfeldt-Jakob disease. Neuroradiology 1993;35:584-585.
29. Röther J, Schwartz A, Härle M. Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease. J Neurol 1992;239:404-406.
30. Tártaro A, Fulgente T, Delli Pizzi C, et al. MRI alterations as an early finding in Creutzfeldt-Jakob disease. Eur J Radiol 1993;17:155-158.
31. Kujat C, Hagen T, Freiden W. Creutzfeldt-Jakob disease. What is the role of magnetic resonance tomography? Radiologie 1995;35:834-837.
32. Murata T, Shiga Y, Higano S, et al. Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. Am J Neuroradiol 2002;23:1164-1172.
33. Urbach H, Klisch J, Wolf HK, et al. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998;40:65-70.
34. Iwasaki Y, Ikeda K, Tagaya N, Kinoshita M. Magnetic resonance imaging and neuropathological findings in 2 patients with Creutzfeldt-Jakob disease. J Neurol Sci 1994;126:228-231.
35. Demaerel P, Sciot R, Robberecht W, et al. Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol 2003;250:222-225.
36. Eschweiler GW, Wormstall H, Widmann U, et al. Correlation of diffusion-weighted magnetic resonance imaging with neurological deficits in sporadic Creutzfeldt-Jakob disease. Nervenarzt 2002;73:883-886.
37. Collins S, Law MG, Fletcher A, et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-697.
38. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extra neural tissues. Lancet 2001;358:208-209.
39. Ward HJ, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002;59:543-548.
40. Korth C, May BC, Cohen FE, Prusiner SB.Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 2001;98:9836-9841.
41. May BC, Fafarman AT, Hong SB, et al.. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc Natl Acad Sci USA 2003;100:3416-3421.
42. Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 2002;52:503-506.